Oregon Public Employees Retirement Fund’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.94M Buy
18,215
+1,374
+8% +$263K 0.04% 323
2026
Q1
$3.09M Buy
16,841
+100
+0.6% +$18.4K 0.04% 353
2025
Q4
$2.95M Hold
16,741
0.04% 360
2025
Q3
$2.35M Buy
16,741
+4,143
+33% +$560K 0.03% 442
2025
Q2
$1.58M Hold
12,598
0.03% 538
2025
Q1
$1.72M Buy
12,598
+110
+0.9% +$15.7K 0.03% 466
2024
Q4
$1.91M Buy
12,488
+52
+0.4% +$8.77K 0.04% 436
2024
Q3
$2.41M Sell
12,436
-60
-0.5% -$12.6K 0.05% 348
2024
Q2
$2.9M Buy
12,496
+100
+0.8% +$21.7K 0.06% 269
2024
Q1
$2.67M Buy
12,396
+1,059
+9% +$248K 0.05% 321
2023
Q4
$2.93M Sell
11,337
-9,305
-45% -$2.29M 0.05% 328
2023
Q3
$5.31M Sell
20,642
-4,162
-17% -$1.11M 0.07% 264
2023
Q2
$7.07M Sell
24,804
-21,926
-47% -$6.53M 0.08% 240
2023
Q1
$13M Sell
46,730
-811
-2% -$224K 0.16% 139
2022
Q4
$13.2M Buy
47,541
+17,546
+58% +$4.96M 0.17% 132
2022
Q3
$8.01M Sell
29,995
-718
-2% -$152K 0.11% 200
2022
Q2
$6.26M Sell
30,713
-18,910
-38% -$3.87M 0.09% 192
2022
Q1
$10.5M Sell
49,623
-3,396
-6% -$738K 0.11% 213
2021
Q4
$12.7M Sell
53,019
-10,418
-16% -$2.68M 0.14% 142
2021
Q3
$18M Buy
63,437
+338
+0.5% +$111K 0.21% 92
2021
Q2
$21.8M Sell
63,099
-11,368
-15% -$3.44M 0.25% 74
2021
Q1
$20.8M Sell
74,467
-672
-0.9% -$181K 0.25% 82
2020
Q4
$18.4M Sell
75,139
-24,266
-24% -$6.26M 0.24% 82
2020
Q3
$28.2M Sell
99,405
-7,627
-7% -$2.13M 0.42% 44
2020
Q2
$28.6M Sell
107,032
-16,619
-13% -$5M 0.42% 44
2020
Q1
$39.1M Buy
123,651
+39,720
+47% +$12.1M 0.67% 24
2019
Q4
$24.9M Buy
83,931
+9,078
+12% +$2.52M 0.35% 55
2019
Q3
$17.4M Buy
74,853
+1,615
+2% +$376K 0.23% 94
2019
Q2
$17.1M Buy
73,238
+25,722
+54% +$5.94M 0.23% 89
2019
Q1
$11.2M Sell
47,516
-35
-0.1% -$11K 0.16% 128
2018
Q4
$14.3M Sell
47,551
-4,069
-8% -$1.3M 0.23% 89
2018
Q3
$18.2M Buy
51,620
+287
+0.6% +$98.8K 0.25% 77
2018
Q2
$14.9M Sell
51,333
-2,975
-5% -$836K 0.22% 87
2018
Q1
$14.9M Buy
54,308
+460
+0.9% +$143K 0.22% 95
2017
Q4
$17.2M Sell
53,848
-2,576
-5% -$826K 0.26% 78
2017
Q3
$17.7M Buy
56,424
+3,844
+7% +$1.14M 0.29% 69
2017
Q2
$14.3M Hold
52,580
0.24% 88
2017
Q1
$14.4M Sell
52,580
-700
-1% -$198K 0.28% 77
2016
Q4
$15.1M Buy
53,280
+800
+2% +$237K 0.31% 66
2016
Q3
$16.4M Buy
52,480
+12,132
+30% +$3.59M 0.35% 56
2016
Q2
$9.76M Sell
40,348
-359
-0.9% -$94.6K 0.22% 99
2016
Q1
$10.6M Buy
40,707
+924
+2% +$244K 0.24% 86
2015
Q4
$12.2M Buy
39,783
+700
+2% +$201K 0.29% 72
2015
Q3
$11.4M Buy
39,083
+314
+0.8% +$104K 0.28% 76
2015
Q2
$15.7M Buy
38,769
+200
+0.5% +$80.3K 0.36% 59
2015
Q1
$16.3M Buy
38,569
+600
+2% +$236K 0.38% 57
2014
Q4
$12.9M Sell
37,969
-9,142
-19% -$2.96M 0.3% 69
2014
Q3
$15.6M Sell
47,111
-300
-0.6% -$98.9K 0.39% 49
2014
Q2
$14.9M Buy
47,411
+1,500
+3% +$451K 0.37% 50
2014
Q1
$14M Sell
45,911
-800
-2% -$254K 0.37% 51
2013
Q4
$13.1M Buy
46,711
+20,700
+80% +$5.35M 0.35% 58
2013
Q3
$6.26M Sell
26,011
-498
-2% -$111K 0.25% 81
2013
Q2
$5.71M Buy
+26,509
New +$5.66M 0.24% 83

Other funds holding BIIB

Oregon Public Employees Retirement Fund's BIIB Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Biogen (BIIB) stake by 8.2% in Q2 2026, buying an estimated $263K and bringing the position to 18,215 shares worth $3.94M. The position accounts for 0.04% of the portfolio, ranked #323.

Oregon Public Employees Retirement Fund first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $39.1M in Q1 2020. 470 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 18,215 shares of Biogen worth $3.94M as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 1,374 Biogen shares in Q2 2026, an estimated $263K.
  • Biogen made up 0.04% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #323 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
  • Oregon Public Employees Retirement Fund's Biogen position peaked at $39.1M in Q1 2020.
  • 470 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.